Is this you? Create Your Porfile
Avatar

Martin Alistair Hayes

University of California, Berkeley

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Martin Alistair Hayes is active.

Explore More

Publication

Featured researches published by Martin Alistair Hayes.

Archive | 2003

Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases

Rachael Ann Ancliff; Caroline Mary Cook; Colin David Eldred; Paul Martin Gore; Lee Andrew GlaxoSmithKline Harrison; Martin Alistair Hayes; Simon Teanby Hodgson; Duncan Bruce Judd; Suzanne Elaine Keeling; Xiao Qing Lewell; Gail Mills; Graeme Michael Robertson; Stephen Swanson; Andrew Walker; Mark GlaxoSmithKline Wilkinson

Archive | 2003

N-2s-4-3,4-difluorobenzyl morpholin-2yl methyl -2-(3-methylsulphonyl amino!phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions

Rachael Ann Ancliff; Caroline Mary Cook; Colin David Eldred; Paul Martin Gore; Lee Andrew GlaxoSmithKline Harrison; Martin Alistair Hayes; Simon Teanby Hodgson; Duncan Bruce Judd; Suzanne Elaine Keeling; Xiao Qing Lewell; Gail Mills; Graeme Michael Robertson; Stephen Swanson; Andrew Walker; Mark GlaxoSmithKline Wilkinson

Archive | 2003

MORPHOLINE DERIVATIVES SUBSTITUTED AT THE 2-POSITION BY A HETEROCYCLYLALKYLUREA GROUP FOR USE AS CCR-3 ANTAGONISTS IN THE TREATMENT OF INFLAMMATORY CONDITIONS

Rachael Ann Ancliff; Caroline Mary Cook; Colin David Eldred; Paul Martin Gore; Lee Andrew GlaxoSmithKline Harrison; Martin Alistair Hayes; Simon Teanby Hodgson; Duncan Bruce Judd; Suzanne Elaine Keeling; Xiao Qing Lewell; Gail Mills; Graeme Michael Robertson; Stephen Swanson; Andrew John Walker; Mark GlaxoSmithKline Wilkinson

Archive | 2003

Morpholine derivatives with a substituted acetamide group in the 2-position for use as ccr-3 antagonists for the treatment of inflammatory diseases

Rachael Ann Ancliff; Caroline Mary Cook; Colin David Eldred; Paul Martin Gore; Lee Andrew Harrison; Martin Alistair Hayes; Simon Teanby Hodgson; Duncan Bruce Judd; Suzanne Elaine Keeling; Xiao Qing Lewell; Gail Mills; Graeme Michael Robertson; Stephen Swanson; Andrew John Walker; Mark Wilkinson

Archive | 2003

Anti-inflammatory morpholin-acetamide derivatives

Rachael Ann Ancliff; Caroline Mary Cook; Colin David Eldred; Paul Martin Gore; Lee Andrew Harrison; Martin Alistair Hayes; Simon Teanby Hodgson; Duncan Bruce Judd; Suzanne Elaine Keeling; Xiao Qing Lewell; Gail Mills; Graeme Michael Robertson; Stephen Swanson; Andrew John Walker; Mark Wilkinson

Archive | 2003

N-(MORPHOLIN-2YL) METHYL ACETAMIDE DERIVATIVES AS CCR-3 ANTAGONISTS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES

Rachael Ann Ancliff; Caroline Mary Cook; Colin David Eldred; Paul Martin Gore; Lee Andrew Harrison; Martin Alistair Hayes; Simon Teanby Hodgson; Duncan Bruce Judd; Suzanne Elaine Keeling; Xiao Qing Lewell; Gail Mills; Graeme Michael Robertson; Stephen Swanson; Andrew John Walker; Mark Wilkinson

Archive | 2003

Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme

Rachael Ann Ancliff; Caroline Mary Cook; Colin David Eldred; Paul Martin Gore; Lee Andrew Harrison; Martin Alistair Hayes; Simon Teanby Hodgson; Duncan Bruce Judd; Suzanne Elaine Keeling; Xiao Qing Lewell; Gail Mills; Graeme Michael Robertson; Stephen Swanson; Andrew John Walker; Mark Wilkinson

Archive | 2003

N- i(2S)-4-(3,4-DIFLUOROBENZYL)MORPHOLIN-2-YL METHYL -2- 3-i(METHYLSULPHONYL)AMINO PHENYL ACETAMID ALS CCR3 ANTAGONIST FÜR DIE BEHANDLUNG VON ENTZÜNDLICHEN ERKRANKUNGEN N i (2S) -4- (3,4-Difluorobenzyl) MORPHOLIN-2-YL METHYL -2- 3-i (methylsulphonyl) AMINO PHENYL ACETAMIDE AS CCR3 ANTAGONIST FOR THE TREATMENT OF INFLAMMATORY DISEASES

Rachael Ann Ancliff; Caroline Mary Cook; Colin David Eldred; Paul Martin Gore; Lee Andrew Harrison; Martin Alistair Hayes; Simon Teanby Hodgson; Duncan Bruce Judd; Suzanne Elaine Keeling; Xiao Qing Lewell; Gail Mills; Graeme Michael Robertson; Stephen Swanson; Andrew John Walker; Mark Wilkinson

Archive | 2003

Morpholine derivatives and intermediates therefor

Rachael Ann Ancliff; Caroline Mary Cook; Colin David Eldred; Paul Martin Gore; Lee Andrew Harrison; Martin Alistair Hayes; Simon Teanby Hodgson; Duncan Bruce Judd; Suzanne Elaine Keeling; Xiao Qing Lewell; Gail Mills; Graeme Michael Robertson; Stephen Swanson; Andrew John Walker; Mark Wilkinson

Archive | 2003

N-{ ` (2s) -4- (3, 4-difluorobenzyle) morpholine-2-yle!methyle} -2-{3-` (methylsulphonyle) amino! phenyle}acetamide utilise en tant qu'antagoniste du recepteur ccr3 pour le traitement d'etats inflammatoires

Rachael Ann Ancliff; Caroline Mary Cook; Colin David Eldred; Paul Martin Gore; Lee Andrew Harrison; Martin Alistair Hayes; Simon Teanby Hodgson; Duncan Bruce Judd; Suzanne Elaine Keeling; Xiao Qing Lewell; Gail Mills; Graeme Michael Robertson; Stephen Swanson; Andrew John Walker; Mark Wilkinson

Explore More

Collaboration

Dive into the Martin Alistair Hayes's collaboration.

Top Co-Authors
Avatar

Caroline Mary Cook

University of California

View shared research outputs
Top Co-Authors
Avatar

Colin David Eldred

University of California

View shared research outputs
Top Co-Authors
Avatar

Gail Mills

University of California

View shared research outputs
Top Co-Authors
Avatar

Stephen Swanson

University of California

View shared research outputs
Top Co-Authors
Avatar

Suzanne Elaine Keeling

University of California

View shared research outputs
Top Co-Authors
Avatar

Rachael Ann Ancliff

University of California

View shared research outputs
Top Co-Authors
Avatar

Duncan Bruce Judd

GlaxoSmithKline

View shared research outputs
Top Co-Authors
Avatar

Paul Martin Gore

GlaxoSmithKline

View shared research outputs
Top Co-Authors
Avatar

Simon Teanby Hodgson

GlaxoSmithKline

View shared research outputs
Top Co-Authors
Avatar

Andrew John Walker

University of Salford

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge